Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Anesthesiology
Volume 2016, Article ID 1630385, 4 pages
http://dx.doi.org/10.1155/2016/1630385
Case Report

High Dose, Prolonged Epsilon Aminocaproic Acid Infusion, and Recombinant Factor VII for Massive Postoperative Retroperitoneal Hemorrhage following Splenectomy

Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA, USA

Received 31 May 2016; Revised 11 October 2016; Accepted 18 October 2016

Academic Editor: Chun-Sung Sung

Copyright © 2016 Alex T. Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Alkjaersig, A. P. Fletcher, and S. Sherry, “ε-aminocaproic acid: an inhibitor of plasminogen activation,” The Journal of Biological Chemistry, vol. 234, no. 4, pp. 832–837, 1957. View at Google Scholar
  2. D. T. Mangano, I. C. Tudor, and C. Dietzel, “The risk associated with aprotinin in cardiac surgery,” The New England Journal of Medicine, vol. 354, no. 4, pp. 353–365, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. D. A. Fergusson, P. C. Hébert, C. D. Mazer et al., “A comparison of aprotinin and lysine analogues in high-risk cardiac surgery,” The New England Journal of Medicine, vol. 358, no. 22, pp. 2319–2331, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Gans and W. Krivit, “Problems in hemostasis during open-heart surgery: III. epsilon aminocaproic acid as an inhibitor of plasminogen activator activity,” Annals of Surgery, vol. 155, pp. 268–276, 1962. View at Google Scholar
  5. American Society of Anesthesiologists Task Force on Perioperative Blood Management, “Practice guidelines for perioperative blood management: an update report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management,” Anesthesiology, vol. 122, no. 2, pp. 241–275, 2015. View at Publisher · View at Google Scholar
  6. D. A. Henry, P. A. Carless, A. J. Moxey et al., “Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion,” Cochrane Database of Systematic Reviews, no. 3, Article ID CD001886, 2011. View at Google Scholar · View at Scopus
  7. Y. K. Kagoma, M. A. Crowther, J. Douketis, M. Bhandari, J. Eikelboom, and W. Lim, “Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials,” Thrombosis Research, vol. 123, no. 5, pp. 687–696, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. M. A. Camarasa, G. Ollé, M. Serra-Prat et al., “Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trial,” British Journal of Anaesthesia, vol. 96, no. 5, pp. 576–582, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. B. J. Harley, L. A. Beaupré, C. A. Jones, J. G. Cinats, and C. R. Guenther, “The effect of epsilon aminocaproic acid on blood loss in patients who undergo primary total hip replacement: a pilot study,” Canadian Journal of Surgery, vol. 45, no. 3, pp. 185–190, 2002. View at Google Scholar · View at Scopus
  10. G. H. Thompson, I. Florentino-Pineda, C. Poe-Kochert, D. G. Armstrong, and J. P. Son-Hing, “The role of amicar in same-day anterior and posterior spinal fusion for idiopathic scoliosis,” Spine, vol. 33, no. 20, pp. 2237–2242, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. J. B. Gill, Y. Chin, A. Levin, and D. Feng, “The use of antifibrinolytic agents in spine surgery: a meta-analysis,” Journal of Bone and Joint Surgery A, vol. 90, no. 11, pp. 2399–2407, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Ortmann, M. W. Besser, and A. A. Klein, “Antifibrinolytic agents in current anaesthetic practice,” British Journal of Anaesthesia, vol. 111, no. 4, pp. 549–563, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Keyl, R. Uhl, F. Beyersdorf et al., “High-dose tranexamic acid is related to increased risk of generalized seizures after aortic valve replacement,” European Journal of Cardio-thoracic Surgery, vol. 39, no. 5, pp. e114–e121, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Martin, J. Knorr, T. Breuer et al., “Seizures after open heart surgery: comparison of ε-aminocaproic acid and tranexamic acid,” Journal of Cardiothoracic and Vascular Anesthesia, vol. 25, pp. 20–25, 2011. View at Google Scholar
  15. R. L. Naeye, “Thrombotic state after a hemorrhagic diathesis, a possible complication of therapy with epsilon aminocaproic acid,” Blood, vol. 19, pp. 694–701, 1962. View at Google Scholar · View at Scopus
  16. G. H. Thompson, I. Florentino-Pineda, D. G. Armstrong, and C. Poe-Kochert, “Fibrinogen levels following Amicar in surgery for idiopathic scoliosis,” Spine, vol. 32, no. 3, pp. 368–372, 2007. View at Publisher · View at Google Scholar · View at Scopus